Results 261 to 270 of about 1,016,101 (284)

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

Cells, 2019
Bruno L Cadilha, Mohamed-Reda Benmebarek, Stefan Endres   +2 more
exaly  

Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22

Molecular Therapy - Oncolytics, 2018
Haiying Qin, Sneha Ramakrishna, Terry Fry   +2 more
exaly  

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase

Molecular Therapy, 2017
Crystal Mackall, Robbie Majzner, Terry Fry   +2 more
exaly  

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity

Cell Stem Cell, 2018
Ye Li, Dan Kaufman
exaly  

CHIMERIC ANTIGEN RECEPTORS FOR PHAGOCYTOSIS

2020
VALE RONALD D, MORRISSEY MEGHAN A, WILLIAMSON ADAM P   +2 more
openaire   +5 more sources

Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell Therapy

Annual Review of Pharmacology and Toxicology, 2016
Zelig Eshhar, Gideon Gross
exaly  

Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells

Molecular Therapy, 2018
Giapietro Dotti, Dongfang Liu, Wei Xiong   +2 more
exaly  

CHIMERIC ANTIGEN RECEPTOR

2013
SHIKU HIROSHI, ORITO YUKI, MINENO JUNICHI, OKAMOTO SACHIKO, AMAISHI YASUNORI   +4 more
openaire   +5 more sources

B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres

EBioMedicine, 2019
Serena Pellegatta, Giapietro Dotti, Bianca Pollo   +2 more
exaly  

CD79A chimeric antigen receptors

2019
FRIEDMAN KEVIN, PERKINS MOLLY REED
openaire   +8 more sources